HOLOGIC INC Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 28 rows in 2019. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2019-12-04: Reporting owner COHN BENJAMIN JORDAN; Form 4; Security Non-qualified Stock Option (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2019-11-22: Reporting owner COHN BENJAMIN JORDAN; Form 4; Security Non-qualified Stock Option (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2019-11-22: Reporting owner Stamoulis Christiana; Form 4; Security Non-qualified Stock Option (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2019-11-11: Reporting owner MACMILLAN STEPHEN P; Form 4; Security Non-qualified Stock Option (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2019-12-04 | COHN BENJAMIN JORDAN Officer (Principal Accounting Officer) | 4 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −4,379 0 owned after | $21.45 exercise price | 2019-12-05 | |
| 2019-11-22 | COHN BENJAMIN JORDAN Officer (Principal Accounting Officer) | 4 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −4,400 4,379 owned after | $21.45 exercise price | 2019-11-26 | |
| 2019-11-22 | Stamoulis Christiana Director | 4 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −12,306 0 owned after | $20.01 exercise price | 2019-11-26 | |
| 2019-11-11 | MACMILLAN STEPHEN P Director, Officer (Chairman, President and CEO) | 4 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −194,396 453,592 owned after | $22.29 exercise price | 2019-11-13 | |
| 2019-11-11 | MACMILLAN STEPHEN P Director, Officer (Chairman, President and CEO) | 4 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −21,600 431,992 owned after | $22.29 exercise price | 2019-11-13 | |
| 2019-11-11 | MACMILLAN STEPHEN P Director, Officer (Chairman, President and CEO) | 4 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +152,529 152,529 owned after | $45.61 exercise price | 2019-11-13 | |
| 2019-11-11 | COHN BENJAMIN JORDAN Officer (Principal Accounting Officer) | 4 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,861 10,861 owned after | $45.61 exercise price | 2019-11-13 | |
| 2019-11-11 | Thornal Kevin R Officer (Div. President, Diagnostics) | 4 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +18,102 18,102 owned after | $45.61 exercise price | 2019-11-13 | |
| 2019-11-11 | Bebo Allison P Officer (SVP, Human Resources) | 4 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,387 15,387 owned after | $45.61 exercise price | 2019-11-13 | |
| 2019-11-11 | Valenti Peter J. III Officer (Division Pres., Breast Health) | 4 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +30,774 30,774 owned after | $45.61 exercise price | 2019-11-13 | |
| 2019-11-11 | Oberton Karleen Marie Officer (Chief Financial Officer) | 4 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +30,774 30,774 owned after | $45.61 exercise price | 2019-11-13 | |
| 2019-11-11 | Griffin John M. Officer (General Counsel) | 4 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +28,964 28,964 owned after | $45.61 exercise price | 2019-11-13 | |
| 2019-09-03 | Valenti Peter J. III Officer (Division Pres., Breast Health) | 4 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −7,766 0 owned after | $23.82 exercise price | 2019-09-05 | |
| 2019-08-05 | MACMILLAN STEPHEN P Director, Officer (Chairman, President and CEO) | 4 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −215,996 647,988 owned after | $22.29 exercise price | 2019-08-07 | |
| 2019-08-05 holding as of filing | Thornal Kevin R Officer (Div. President, Diagnostics) | 3 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | Holding | $40.97 exercise price | 2019-08-05 | ||
| 2019-08-05 holding as of filing | Thornal Kevin R Officer (Div. President, Diagnostics) | 3 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | Holding | $39.96 exercise price | 2019-08-05 | ||
| 2019-08-05 holding as of filing | Thornal Kevin R Officer (Div. President, Diagnostics) | 3 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | Holding | $37.64 exercise price | 2019-08-05 | ||
| 2019-08-05 holding as of filing | Thornal Kevin R Officer (Div. President, Diagnostics) | 3 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | Holding | $40.85 exercise price | 2019-08-05 | ||
| 2019-08-05 holding as of filing | Thornal Kevin R Officer (Div. President, Diagnostics) | 3 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | Holding | $26.01 exercise price | 2019-08-05 | ||
| 2019-03-18 | CRAWFORD SALLY Director | 4 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −12,306 0 owned after | $20.01 exercise price | 2019-03-20 | |
| 2019-03-11 | COHN BENJAMIN JORDAN Officer (Principal Accounting Officer) | 4 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −6,830 0 owned after | $19.86 exercise price | 2019-03-13 | |
| 2019-03-07 | Wendell Amy McBride Director | 4 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +6,523 6,523 owned after | $46.81 exercise price | 2019-03-12 | |
| 2019-03-07 | Stamoulis Christiana Director | 4 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +6,523 6,523 owned after | $46.81 exercise price | 2019-03-11 | |
| 2019-03-07 | Nawana Namal Director | 4 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +6,523 6,523 owned after | $46.81 exercise price | 2019-03-11 | |
| 2019-03-07 | HANTSON LUDWIG Director | 4 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +6,523 6,523 owned after | $46.81 exercise price | 2019-03-11 | |
| 2019-03-07 | GARRETT SCOTT T Director | 4 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +6,523 6,523 owned after | $46.81 exercise price | 2019-03-11 | |
| 2019-03-07 | Dockendorff Charles J Director | 4 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +6,523 6,523 owned after | $46.81 exercise price | 2019-03-11 | |
| 2019-03-07 | CRAWFORD SALLY Director | 4 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +6,523 6,523 owned after | $46.81 exercise price | 2019-03-11 |